Insiders Ultragenyx Pharmaceutical Inc.

Equities

RARE

US90400D1081

Market Closed - Nasdaq Other stock markets 21:00:00 09/05/2024 BST			5-day change	1st Jan Change
41.22 ^USD	-0.82%		-4.58%	-13.80%

05-03	Wedbush Adjusts Ultragenyx Pharmaceutical's Price Target to $47 From $48, Keeps Neutral Rating	MT
05-02	Transcript : Ultragenyx Pharmaceutical Inc., Q1 2024 Earnings Call, May 02, 2024

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ultragenyx Pharmaceutical Insider Sold Shares Worth $574,644, According to a Recent SEC Filing	03-12	MT
Ultragenyx Pharmaceutical Insider Sold Shares Worth $1,436,100, According to a Recent SEC Filing	01-02	MT
Ultragenyx Pharmaceutical Insider Sold Shares Worth $1,307,201, According to a Recent SEC Filing	24/10/23	MT
Insider Sell: Ultragenyx Pharmaceutical	06/09/23	MT
Ultragenyx Pharmaceutical Names Howard Horn Chief Financial Officer	12/07/23	MT
Ultragenyx Pharmaceutical Inc. Appoints Howard Horn as Executive Vice President Effective October 16, 2023	12/07/23	CI
Ultragenyx Pharmaceutical Inc. Announces Appointment of Howard Horn as Chief Financial Officer, Effective October 16, 2023	12/07/23	CI
Insider Sell: Ultragenyx Pharmaceutical	19/05/23	MT
Insider Sell: Ultragenyx Pharmaceutical	05/05/23	MT
Dennis Huang of Ultragenyx Named to MassBio’s Board of Directors	28/04/23	AQ
Ultragenyx Pharmaceutical Inc. Announces Retirement of Lars Ekman as Board of Directors	23/03/23	CI
Ultragenyx Pharmaceutical Inc. Appoints Dr. Eric Crombez Chief Medical Officer and Executive Vice President	14/03/23	CI
Ultragenyx Pharmaceutical Chief Financial Officer Mardi Dier to Depart for Private Biopharma Company	11/11/22	MT
Ultragenyx Pharmaceutical Inc. Announces Departure of Mardi Dier, Executive Vice President	10/11/22	CI
Insider Sell: Ultragenyx Pharmaceutical	14/10/22	MT
Ultragenyx Pharmaceutical Inc. Announces William Aliski Will Not Stand for Re-Election as A Member of the Board of Directors	22/04/22	CI
Ultragenyx Pharmaceutical Inc. Announces the Appointment of Amrit Ray to Board of Directors	22/04/22	CI
Insider Sell: Ultragenyx Pharmaceutical	15/03/22	MT
Insider Sell: Ultragenyx Pharmaceutical	08/03/22	MT
Spruce Biosciences Names Javier Szwarcberg as CEO	05/01/22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Ultragenyx Pharmaceutical Inc.

Equities

RARE

US90400D1081

Insiders

Filters